Hyperion Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Hyperion Partners's AMGN Position: Q3 2024 in Review
Hyperion Partners reduced its Amgen (AMGN) stake by 2.7% in Q3 2024, selling an estimated $6.54K and leaving 712 shares worth $229K. The position accounts for 0.15% of the portfolio, ranked #65.
Hyperion Partners first reported a position in AMGN in Q4 2022 and has held it in 8 quarters since. The position peaked at $423K in Q4 2023. 2,828 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.
- Hyperion Partners held 712 shares of Amgen worth $229K as of Q3 2024.
- Hyperion Partners sold 20 Amgen shares in Q3 2024, an estimated $6.54K.
- Amgen made up 0.15% of Hyperion Partners's portfolio in Q3 2024, its #65 holding.
- Hyperion Partners first reported a position in Amgen in Q4 2022 and has held it in 8 quarters since.
- Hyperion Partners's Amgen position peaked at $423K in Q4 2023.
- 2,828 funds tracked by Wall St. Rank held Amgen as of Q3 2024.
Based on Hyperion Partners's 13F filing for Q3 2024, filed 9 Oct 2024.